✦ LIBER ✦

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by Posner, M R; Lefebvre, J L

Book ID: 109997443
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 108 KB
Volume: 88
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600685

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost utility of docetaxel as induction c

Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck

✍ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5‐fluorouracil (TPF) compared with cisplatin and 5‐fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN

Preoperative sequential chemotherapy in

Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck

✍ Sandrine Faivre; Adina Marti; Olivier Rixe; François Janot; Morbize Julieron; Mi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

## Abstract ## Background. Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure. ## Methods. Patients with previously untreated locally advanced stage III–IV (N0

Sequential chemo-radiotherapy in locally

Sequential chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck

✍ Thomas G. Wendt; Michael Chucholowski; Reiner Hartenstein; Ralf Rohloff; Normann 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Hyperfractionated radiotherapy in advanc

Hyperfractionated radiotherapy in advanced squamous cell carcinoma of the head and neck

✍ Tan Dat Nguyen; Xavier Panis; Michel Legros; Dominique Froissart 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime